Controversies over the treatment for stage Ⅲ A-N2 non-small cell lung cancer and related advances
10.3760/cma.j.issn.1004-4221.2017.04.023
- VernacularTitle:ⅢA-N2期NSCLC治疗争议与进展
- Author:
Wei HAN
;
Xueying QIAO
- Keywords:
Carcinoma,non-small cell lung/surgery;
Carcinoma,non-small cell lung/radiotherapy;
ⅢA-N2 stage
- From:
Chinese Journal of Radiation Oncology
2017;26(4):470-473
- CountryChina
- Language:Chinese
-
Abstract:
Stage Ⅲ A non-small cell lung cancer (NSCLC) has high heterogeneity and there are some controversies over the treatment of this disease,especially for patients with stage ⅢA-N2 NSCLC.This article investigates whether preoperative or postoperative radiotherapy can improve the survival of patients with stage ⅢA-N2 NSCLC and evaluates the effect of surgical treatment.
